MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1161/jaha.124.034893

Медицинская библиотека · Journal of the American Heart Association · 2024

Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies.

Lazzerini Pietro Enea, Bertolozzi Iacopo, Cartocci Alessandra, Ginjupalli Vamsi Krishna Murthy, Teneggi Pietro Alberto, Pica Davide, Merico Giovanni, Bogazzi Irene, Salvini Viola, Accioli Riccardo, Salvadori Fabio, Marzotti Tommaso, Cevenini Gabriele, Capecchi Matteo, Cantara Silvia, Cantore Anna, Infantino Maria, Bisogno Stefania, Finizola Francesco, D'ascenzi Flavio, Laghi-Pasini Franco, Acampa Maurizio, Capecchi Pier Leopoldo, Boutjdir Mohamed

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Advanced atrioventricular block (AVB), that is, higher than second-degree Mobitz-1, is an abnormal finding in athletes. Despite intensive investigation, in several cases the pathogenesis remains unknown, but frequently pacemaker implantation is still indicated. Increasing evidence points to circulating anti-Ro/Sjögren syndrome-related antigen A (SSA) antibodies cross-reacting with L-type calcium channel and inhibiting the related current as an epidemiologically relevant and potentially reversible cause of isolated AVB in adults. The aim of the study was to determine the prevalence of anti-Ro/SSA-associated advanced AVBs in a large sample of young athletes.

METHODS AND

RESULTS

A total of 2536 consecutive athletes aged <40 years without a history of cardiac diseases/interventions were enrolled in a cross-sectional study. Resting and exercise electrocardiography was performed, and those presenting any AVB were further evaluated by 24-hour Holter ECG. Athletes with second-degree AVBs and their mothers underwent anti-Ro/SSA testing. Moreover, purified immunoglobulin G from subjects with anti-Ro/SSA-positive and anti-Ro/SSA-negative advanced AVB were tested on L-type calcium current and L-type-calcium channel expression using tSA201 cells. The global prevalence of advanced AVB in the overall sample was ≈0.1%, but the risk considerably increased (2%) when intensely trained postpubertal male subjects were selectively considered. While none of the athletes with advanced AVB showed heart abnormalities, in 100% of cases anti-Ro/SSA antibodies were detected. Ex vivo experiments showed that immunoglobulin G from anti-Ro/SSA-positive but not -negative subjects with advanced AVB acutely inhibit L-type calcium current and chronically downregulate L-type-calcium channel expression.

CONCLUSIONS

Our study provides evidence that advanced AVB occurs in young athletes, in most cases associated with anti-Ro/SSA antibodies blocking L-type calcium channels. These findings may open new avenues for immunomodulating therapies to reduce the risk of life-threatening events in athletes, avoiding or delaying pacemaker implantation.

Для цитирования: Lazzerini Pietro Enea, Bertolozzi Iacopo, Cartocci Alessandra, Ginjupalli Vamsi Krishna Murthy, Teneggi Pietro Alberto, Pica Davide, Merico Giovanni, Bogazzi Irene, Salvini Viola, Accioli Riccardo, Salvadori Fabio, Marzotti Tommaso, Cevenini Gabriele, Capecchi Matteo, Cantara Silvia, Cantore Anna, Infantino Maria, Bisogno Stefania, Finizola Francesco, D'ascenzi Flavio, Laghi-Pasini Franco, Acampa Maurizio, Capecchi Pier Leopoldo, Boutjdir Mohamed. Advanced Atrioventricular Block in Athletes: Prevalence and Role of Anti-Ro/Sjögren Syndrome-Related Antigen A Antibodies.. Journal of the American Heart Association. 2024. DOI: 10.1161/jaha.124.034893.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.